These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6136997)

  • 1. Relationships between plasma levels and psychological effects of benzodiazepines.
    Ziegler G; Ludwig L; Klotz U
    Pharmacopsychiatria; 1983 May; 16(3):71-6. PubMed ID: 6136997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of tranquilizers on the critical flicker fusion frequency in the visual analyzer].
    Ben'kovich BI; Marshak OV
    Fiziol Cheloveka; 1984; 10(6):999-1004. PubMed ID: 6151932
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam.
    Kurowski M; Ott H; Herrmann WM
    Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of betel nut on human performance.
    Frewer LJ
    P N G Med J; 1990 Jun; 33(2):143-5. PubMed ID: 2238827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of alcohol and other drugs on psychomotor performance and cognitive function.
    Hindmarch I; Kerr JS; Sherwood N
    Alcohol Alcohol; 1991; 26(1):71-9. PubMed ID: 1854375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects (author's transl)].
    Crevoisier C; Eckert M; Heizmann P; Thurneysen DJ; Ziegler WH
    Arzneimittelforschung; 1981; 31(12a):2211-5. PubMed ID: 6120700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pharmacodynamic properties of psychotropic drugs: quanitative EEG, psychometric and blood level investigations in normals and patients.
    Saletu B; Grünberger J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):45-58. PubMed ID: 419165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of phenazepam on psychophysiological reactions].
    Morozov IS; Rubtsov AT; Braga VV
    Farmakol Toksikol; 1980; 43(1):33-6. PubMed ID: 6103818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of computerized psychomotor testing in determining CNS effects of drugs.
    Berchou R; Block RI
    Percept Mot Skills; 1983 Dec; 57(3 Pt 1):691-700. PubMed ID: 6664751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 150 mg fluconazole does not substantially increase the effects of 10 mg midazolam or the plasma midazolam concentrations in healthy subjects.
    Vanakoski J; Mattila MJ; Vainio P; Idänpään-Heikkilä JJ; Törnwall M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):518-23. PubMed ID: 8520811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacokinetics of midazolam, flunitrazepam and diazepam (author's transl)].
    Lauven PM; Stoeckel H; Schwilden H; Schüttler J
    Anasth Intensivther Notfallmed; 1981 Jun; 16(3):135-42. PubMed ID: 6114680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midazolam: effects on psychomotor performance and subjective aspects of sleep and sedation in normal volunteers.
    Gudgeon AC; Hindmarch I
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):121S-126S. PubMed ID: 6138064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam.
    Chernik DA; Gillings D; Laine H; Hendler J; Silver JM; Davidson AB; Schwam EM; Siegel JL
    J Clin Psychopharmacol; 1990 Aug; 10(4):244-51. PubMed ID: 2286697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
    Schaffler K; Kauert G; Wauschkuhn CH; Klausnitzer W
    Arzneimittelforschung; 1989 Feb; 39(2):276-83. PubMed ID: 2567171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of triazolam and nitrazepam on sleep quality, morning vigilance and psychomotor performance.
    Hindmarch I; Clyde CA
    Arzneimittelforschung; 1980; 30(7):1163-6. PubMed ID: 6106500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication.
    Hindmarch I; Parrott AC
    Arzneimittelforschung; 1978; 28(11):2169-72. PubMed ID: 40568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
    Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
    J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal midazolam plasma concentration profile and its effect on anxiety associated with dental procedures.
    Burstein AH; Modica R; Hatton M; Gengo FM
    Anesth Prog; 1996; 43(2):52-7. PubMed ID: 10323126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.